Transcriptional Regulation by P53

Cited by (575)

Items 301–400 of 575

1. Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
   Huan Li, Chao Song, Yang Zhang, Guohao Liu, Hailong Mi, Yachao Li, Zhiye Chen, Xiaoyu Ma, Po Zhang, Lidong Cheng et al. · 2023 · Advanced Science
2. Late Cornified Envelope Group I, a Novel Target of p53, Regulates PRMT5 Activity
   Zhenzhong Deng, Koichi Matsuda, Chizu Tanikawa, Jia-Yin Lin, Yoichi Furukawa, Ryuji Hamamoto, Yusuke Nakamura · 2014 · Neoplasia
3. Mutant p53 as an Antigen in Cancer Immunotherapy
   Navid Sobhani, Alberto D’Angelo, Xu Wang, Ken H. Young, Daniele Generali, Yong Li · 2020 · International Journal of Molecular Sciences
4. Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
   M Charni, Alina Molchadsky, Ido Goldstein, Hilla Solomon, Perry Tal, Naomi Goldfinger, Peirong Yang, Ziv Porat, Guillermina Lozano, Varda Rotter · 2015 · Cell Death and Differentiation
5. Calcium/calmodulin–dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation
   Kellie E. Cunningham, Elizabeth A. Novak, Garret Vincent, Vei Shaun Siow, Brian D. Griffith, Sarangarajan Ranganathan, Matthew Randall Rosengart, Jon D. Piganelli, Kevin Patrick Mollen · 2018 · The FASEB Journal
6. Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies
   Katsutoshi Oda, Yuji Ikeda, Tomoko Kashiyama, Aki Miyasaka, Kanako Inaba, Tomohiko Fukuda, Kayo Asada, Kenbun Sone, Osamu Wada‐Hiraike, Kei Kawana et al. · 2016 · Journal of obstetrics and gynaecology research
7. Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells
   Sony Pandey, Jennifer R. Bourn, Maria Cekanova · 2018 · Oncotarget
8. Autophagic Organelles in DNA Damage Response
   Jeongha Kim, Sung-Min Lee, Hyun‐Woo Kim, Haksoo Lee, Ki Moon Seong, HyeSook Youn, BuHyun Youn · 2021 · Frontiers in Cell and Developmental Biology
9. The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein
   Václav Brázda, Jana Čechová, Michele Battistin, Jan Coufal, Eva B. Jagelská, Ivan Raimondi, Alberto Inga · 2016 · Biochemical and Biophysical Research Communications
10. Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
    Luiza Steffens Reinhardt, Xiajie Zhang, Kira Groen, Brianna C. Morten, Geoffry Nunzio De Iuliis, Antony W. Braithwaite, Jean‐Christophe Bourdon, Kelly A. Avery‐Kiejda · 2022 · Cell Death and Disease
11. Multifaceted functions of Siva-1: more than an Indian God of Destruction
    Yide Mei, Mian Wu · 2012 · Protein & Cell
12. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53
    Howard E. Boudreau, Wei Feng, Agnieszka Korzeniowska, Jonathan Joon-Young Park, Medha Bhagwat, Thomas L. Leto · 2017 · Oncotarget
13. The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury
    Saravanakumar Selvaraj, Jung‐Hwa Oh, Reinhard Spanel, Florian Peter Länger, Hyoung‐Yun Han, Eun Hee Lee, Seokjoo Yoon, Jürgen T. Borlak · 2017 · Oncotarget
14. The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas
    Makoto Miyazaki, Ryo Otomo, Yuko Matsushima‐Hibiya, Hidenobu Suzuki, Ayana Nakajima, Naomi Abe, Arata Tomiyama, Koichi Ichimura, Koichi Matsuda, Toshiki Watanabe et al. · 2018 · Cell Death Discovery
15. The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders
    Yuan Zhou, Runzhe Chen, Xiaofang Luo, Weidong Zhang, Jiang‐Jiang Qin · 2020 · Drug Discovery Today
16. TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma
    Khadija Rebbani, Agnès Marchio, Sayeh Ezzikouri, R. Afifi, Mostafa Kandil, Olfa Bahri, Henda Triki, Abdellah Essaid El Feydi, Anne Dejean, Soumaya Benjelloun et al. · 2015 · Molecular Cancer
17. Testosterone modulates FoxO3a and p53-related genes to protect C2C12 skeletal muscle cells against apoptosis
    Lucía Pronsato, Lorena M. Milanesi, Andrea Vasconsuelo, Anabela Belén la Colla · 2017 · Steroids
18. Identification of p53-target genes in Danio rerio
    Barbara Mandriani, Stefano Castellana, Carmela Rinaldi, Marta Manzoni, Santina Venuto, Eva Rodríguez-Aznar, Joan Galcerán, Maria Angela Nieto, Giuseppe Borsani, Eugenio Monti et al. · 2016 · Scientific Reports
19. Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer
    Caroline Kreuzinger, Isabel von der Decken, Andrea M. Wolf, Magdalena Gamperl, Júlia Koller, Jasmine Karacs, Stephanie Pfaffinger, Thomas Bartl, Alexander Reinthaller, Christoph Grimm et al. · 2019 · Cancer Letters
20. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC
    Lei Duan, Ricardo E. Perez, Sarah Calhoun, Carl G. Maki · 2022 · Scientific Reports
21. Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis
    Akihiko Ishimura, Minoru Terashima, Shoichiro Tange, Takeshi Suzuki · 2015 · Cell and Tissue Research
22. Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53
    Georges Kalouche, Céline Boucher, Annick Coste, Laurent Debüssche, Cécile Orsini, Christophe Baudouin, Thomas Debeir, Xavier Vigé, William H. Rostène · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
23. Stress-induced p53 drives BAG5 cochaperone expression to control α-synuclein aggregation in Parkinson's disease
    Huan-Yun Chen, Chin‐Hsien Lin, Shu‐Chun Teng · 2020 · Aging
24. Transcriptional repression of IKKβ by p53 in arsenite-induced GADD45α accumulation and apoptosis
    Yongliang Hu, Rui Jin, Ming Gao, Huan Xu, Shuxian Zou, Xiaoguang Li, Xing Chen, Qiyu Wang, Hongli Wang, Jiannan Feng et al. · 2018 · Oncogene
25. Pan-cancer investigation reveals mechanistic insights of planar cell polarity gene Fuz in carcinogenesis
    Zhefan Stephen Chen, Xiao Lin, Ting‐Fung Chan, Ho Yin Edwin Chan · 2021 · Aging
26. p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities
    David R. Tong, Wen Zhou, Chen Katz, Kausik Regunath, Divya Venkatesh, Chinyere Ihuegbu, James J. Manfredi, Oleg Laptenko, Carol L. Prives · 2021 · Molecular Cancer Research
27. High Levels of Wild-Type BRCA2 Suppress Homologous Recombination
    Alissa C. Magwood, Maureen M. Mundia, Mark D. Baker · 2012 · Journal of Molecular Biology
28. Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: A potential novel prognostic marker for breast cancer
    Gehad Youssef, Cheryl Gillett, Orunsola Agbaje, Tessa Crompton, Ximena Montano · 2013 · Modern Pathology
29. Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
    Surinder M. Soond, Lyudmila V. Savvateeva, Vladimir A. Makarov, Neonila V. Gorokhovets, Paul A. Townsend, Andrey A. Zamyatnin · 2020 · Cancers
30. Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
    Mayra A. Marques, Guilherme Caldas de Andrade, Jerson Lima Silva, Guilherme A. P. de Oliveira · 2022 · Frontiers in Molecular Biosciences
31. Tumour suppressors and cellular senescence
    Adelyne Sue Li Chan, Sophia N. Mowla, Parineeta Arora, Parmjit Jat · 2014 · IUBMB Life
32. Antitumor activity of RT2 peptide derived from crocodile leukocyte peptide on human colon cancer xenografts in nude mice
    Pornsuda Maraming, Sompong Klaynongsruang, Patcharee Boonsiri, Surachai Maijaroen, Sakda Daduang, Jing‐Gung Chung, Jureerut Daduang · 2018 · Environmental Toxicology
33. A mini-review of the diffusion dynamics of DNA-binding proteins: experiments and models
    Seongyu Park, O-chul Lee, Xavier Durang, Jae-Hyung Jeon · 2021 · Journal of the Korean Physical Society
34. p53‐mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells
    Young Yeon Kim, Jee‐Hyun Um, Dong Jin Shin, Dae Jin Jeong, Young Bin Hong, Jeanho Yun · 2021 · The FASEB Journal
35. The actin nucleation factors JMY and WHAMM enable a rapid Arp2/3 complex-mediated intrinsic pathway of apoptosis
    Virginia L. King, Nathan K. Leclair, Alyssa M. Coulter, Kenneth G. Campellone · 2021 · PLoS Genetics
36. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites
    Catherine A. Vaughan, Swati Palit Deb, Sumitra Deb, Brad E. Windle · 2014 · Oncotarget
37. Discovery of new low-molecular-weight p53–Mdmx disruptors and their anti-cancer activities
    Shinichi Uesato, Yoshihiro Matsuura, Saki Matsue, Takaaki Sumiyoshi, Yoshiyuki Hirata, Suzuho Takemoto, Yasuyuki Kawaratani, Yu‐suke Yamai, Kyoji Ishida, Tsutomu Sasaki et al. · 2016 · Bioorganic & Medicinal Chemistry
38. Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
    Shraddha Patel, Chandrabhan Prajapati, Sachchida Nand, Santosh Kumar Singh · 2026 · 3 Biotech
39. Benzo[a]pyrene induces NLRP1 expression and promotes prolonged inflammasome signaling
    Risa Kohno, Yuka Nagata, Tomohiro Ishihara, Chisato Amma, Yayoi Inomata, Takafumi Seto, Ryo Suzuki · 2023 · Frontiers in Immunology
40. Haematopoietic stem cell-dependent Notch transcription is mediated by p53 through the Histone chaperone Supt16h
    Sophia G. Espanola, Hyemin Song, Eunjin Ryu, Aditya Saxena, Eun Sun Kim, Jennifer E. Manegold, Chanond A. Nasamran, Debashis Sahoo, Chang‐Kyu Oh, Cara Bickers et al. · 2020 · Nature Cell Biology
41. E2F1 and p53 Transcription Factors as Accessory Factors for Nucleotide Excision Repair
    Renier Vélez-Cruz, David G. Johnson · 2012 · International Journal of Molecular Sciences
42. FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status
    Nobuo Tsuchida, Masa‐Aki Ikeda, Yoshizumi Ishino, Michèle Grieco, Giancarlo Vecchio · 2017 · International Journal of Oncology
43. CSAG2 is a cancer‐specific activator of SIRT1
    Xu Yang, Patrick Ryan Potts · 2020 · EMBO Reports
44. Structural Visualization of the p53/RNA Polymerase II Assembly
    Sameer Kumar Singh, Zhen Qiao, Lihua Song, Vijay Jani, William Rice, Edward Eng, Robert A. Coleman, Weili Liu · 2016 · Biophysical Journal
45. Cancer, Natural Products and Nanodrug Delivery Systems
    Yong Sze Ong, Loh Teng‐Hern Tan · 2020 · Progress In Microbes & Molecular Biology
46. The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling
    Alhanouf A. Aljohani, Yasmeen S. Alqarni, Maram N. Alrashidi, Maha H. Aljuhani, Shaimaa A. Shehata, Mohamed K. El-Kherbetawy, Kousalya Prabahar, Reem Alshaman, Abdullah Alattar, Ahmed Mohamed Helaly et al. · 2022 · Toxics
47. Pifithrin-α provides neuroprotective effects at the level of mitochondria independently of p53 inhibition
    Sandra Neitemeier, Goutham K. Ganjam, Sebastian Diemert, Carsten Culmsee · 2014 · APOPTOSIS
48. Preservation of cardiac function in left ventricle cardiac hypertrophy using an AAV vector which provides VEGF-A expression in response to p53
    Marcio Chaim Bajgelman, Leonardo dos Santos, Gustavo José Justo da Silva, Juliana Sanajotti Nakamuta, Raquel A. Sirvente, Márcio José Figueira Chaves, José Eduardo Krieger, Bryan Eric Strauss · 2014 · Virology
49. p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA‐dependent interaction
    Huda H. Al‐Khalaf, Shreeram C. Nallar, Dhananjaya V. Kalvakolanu, Abdelilah Aboussekhra · 2017 · Molecular Carcinogenesis
50. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21Waf1/Cip1
    Yi Sui, Tingting Wu, Fuqiang Li, Fei Wang, Yong Cai, Jingji Jin · 2019 · International Journal of Molecular Sciences
51. Non-Structural Protein 5 of Zika Virus Interacts with p53 in Human Neural Progenitor Cells and Induces p53-Mediated Apoptosis
    Ping Li, Hualian Jiang, Hong Peng, Weijie Zeng, Yongheng Zhong, Miao He, Luyang Xie, Junhai Chen, Deyin Guo, Junyu Wu et al. · 2021 · Virologica Sinica
52. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill
    Xiaolei Xie, Guangan He, Zahid Hussain Siddik · 2020 · Molecular Pharmacology
53. B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma
    Malin Nientiedt, K. Müller, Katja Nitschke, Philipp Erben, Annette Steidler, Štefan Porubský, Zoran V. Popović, Frank Waldbillig, Julia Mühlbauer, MAXIMILIAN CHRISTIAN KRIEGMAIR · 2020 · Journal of Cancer Research and Clinical Oncology
54. Comparison of Anticancer, Antioxidant, Enzyme Inhibitory Effects and Phytochemical Contents Between Edible Lettuce (Lactuca sativa) and a New Wild Species (Lactuca anatolica)
    Mehmet Kadir Erdoğan, Ramazan Gündoğdu, Yusuf Toy, İbrahim Halil Geçibesler, Yakup Yapar, Lütfi Behçet, Gökhan Zengin · 2024 · Chemistry & Biodiversity
55. GFI1 Is Repressed by p53 and Inhibits DNA Damage-Induced Apoptosis
    Pei Du, Fangqiang Tang, Yaling Qiu, Fan Dong · 2013 · PLoS ONE
56. The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines.
    Mehdi Nikbakht Dastjerdi, Mohammad Reza Salahshoor, Mohammad Mardani, Mohammad Rabbani, Batool Hashemibeni, Marjan Gharagozloo, Mohammad Kazemi, Nafiseh Esmaeil, Shiva Roshankhah, Rahim Golmohammadi et al. · 2013 · Europe PMC (PubMed Central)
57. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition
    Thomas Albert, Claudia Antrecht, Elisabeth Kremmer, Michael Meisterernst · 2016 · PLoS ONE
58. Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
    Christian S. Álvarez, Jeremy Ortiz, Giovanna Bendfeldt‐Avila, Yi Xie, Mingyi Wang, Dongjing Wu, Herbert Higson, Elisa Lee, Kedest Teshome, Joaquín Barnoya et al. · 2020 · Health Science Reports
59. Viral interactions with non-homologous end-joining: a game of hide-and-seek
    Dayana B. Hristova, Katharina Barbara Lauer, Brian J. Ferguson · 2020 · Journal of General Virology
60. Reciprocal modulation of long noncoding RNA EMS and p53 regulates tumorigenesis
    Chenfeng Wang, Yang Yang, Xianning Wu, Jingxin Li, Kaiyue Liu, Debao Fang, Bingyan Li, Ge Shan, Xinyu Mei, Fang Wang et al. · 2022 · Proceedings of the National Academy of Sciences
61. Epidermal growth factor prevents thallium(I)- and thallium(III)-mediated rat pheochromocytoma (PC12) cell apoptosis
    María Teresa Pino, Clarisa Marotte, Sandra Viviana Verstraeten · 2016 · Archives of Toxicology
62. Hypothermia modulates the DNA damage response to ionizing radiation in human peripheral blood lymphocytes
    Halina Lisowska, Lei Cheng, Alice Sollazzo, Lovisa Lundholm, Aneta Węgierek-Ciuk, Sylwester Sommer, Anna Lankoff, Andrzej Wójcik · 2018 · International Journal of Radiation Biology
63. Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo
    Juliana Goulart Xande, Ana Paula Dias, Rodrigo Esaki Tamura, Mário Costa Cruz, Bárbara Brito, Robledo A. Ferreira, Bryan Eric Strauss, Eugênia Costanzi-Strauss · 2019 · Gene Therapy
64. The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress
    Man I Kuan, John M. O’Dowd, Elizabeth A. Fortunato · 2016 · Virology
65. Context-Dependent Function of Long Noncoding RNA PURPL in Transcriptome Regulation during p53 Activation
    Corrine Corrina R. Hartford, Roshan L. Shrestha, Lőrinc Sándor Pongor, Yongmei Zhao, Xiongfong Chen, Caroline Fromont, Ritu Chaudhary, Xiao Ling Li, Katherine R. Pasterczyk, Ravi Shekhar Kumar et al. · 2022 · Molecular and Cellular Biology
66. Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay
    Mattia Lion, Ivan Raimondi, Stefano Donati, Olivier Jousson, Yari Ciribilli, Alberto Inga · 2015 · PLoS ONE
67. Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
    Robert D. Kendig, Fumitake Kai, Elizabeth A. Fry, Kazushi Inoue · 2017 · Cancer Investigation
68. Tissue and cell-type-specific transduction using rAAV vectors in lung diseases
    Konstantin S. Kochergin-Nikitsky, Lyubava Belova, А. В. Лавров, Svetlana Smirnikhina · 2021 · Journal of Molecular Medicine
69. HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1
    Stefanie Schuller, Jan Sieker, Philip Riemenschneider, Bianca Köhler, Elisabeth Drucker, Sofia M.E. Weiler, Daniel Dauch, Carsten Sticht, Benjamin Frank Goeppert, Stephanie K. Roessler et al. · 2022 · Cancers
70. AAVPG: A vigilant vector where transgene expression is induced by p53
    Marcio Chaim Bajgelman, Ruan F.V. Medrano, A.C. Carvalho, Bryan Eric Strauss · 2013 · Virology
71. Molecular Basis for Modulation of the p53 Target Selectivity by KLF4
    Tobias Brandt, Fiona M. Townsley, Daniel P. Teufel, Stefan M.V. Freund, Dmitry B. Veprintsev · 2012 · PLoS ONE
72. The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
    Kensuke Kojima, Aya Maeda, Mariko Yoshimura, Yuki Nishida, Shinya H Kimura · 2016 · Oncotarget
73. TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation
    Ryo Maeda, Hiroyuki Tamashiro, Kazunori Takano, Hiro Takahashi, Hidefumi Suzuki, Shinta Saito, Waka Kojima, Noritaka Adachi, Kiyoe Ura, Takeshi Endo et al. · 2017 · Journal of Biological Chemistry
74. Wild Type p53 Transcriptionally Represses the SALL2 Transcription Factor under Genotoxic Stress
    Carlos Farkas, Carla P. Martins, David Escobar, Matías I. Hepp, David B. Donner, Ariel Fernando Castro, Gérard I. Evan, José Leonardo Gutiérrez, Robert S. Warren, Roxana Pincheira · 2013 · PLoS ONE
75. High‐fluence light emitting diode‐red light inhibits cell cycle progression in human dermal fibroblasts
    Natasha Masub, Evan Austin, Alisen Huang, Jared R. Jagdeo · 2020 · Journal of Biophotonics
76. Structure of the p53/RNA polymerase II assembly
    Shu-Hao Liou, Sameer Kumar Singh, Robert H. Singer, Robert A. Coleman, Wei-Li Liu · 2021 · Communications Biology
77. Functional analyses of human DNA repair proteins important for aging and genomic stability using yeast genetics
    Monika Aggarwal, Robert M. Brosh · 2012 · DNA repair
78. 2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53
    Paolo Luca Mattiolo, Ares Barbero-Farran, Vı́ctor J. Yuste, Jacint Boix, Judit Ribas · 2014 · Biochemical Pharmacology
79. Methods to Study Metastasis in Genetically Modified Mice
    Farhia Kabeer, Levi J. Beverly, Guillaume Darrasse-Jèze, Katrina Podsypanina · 2016 · Cold Spring Harbor Protocols
80. Promoter-proximal regulation of gene transcription: Key factors involved and emerging role of general transcription factors in assisting productive elongation
    Sujay Pal, Debabrata Biswas · 2023 · Gene
81. Dicoma anomala Enhances Phthalocyanine Mediated Photodynamic Therapy in MCF-7 Breast Cancer Cells
    Alexander Chota, Blassan Plackal Adimuriyil George, Heidi Abrahamse · 2022 · Frontiers in Pharmacology
82. The p53 gene with emphasis on its paralogues in mosquitoes
    Tien-Huang Chen, Yijun Wu, Jiun-Nan Hou, Cheng‐Hsun Chiu, Wei‐June Chen · 2017 · Journal of Microbiology Immunology and Infection
83. ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage
    Harsh Patel, M. Saeed Sheikh, Ying Kao Huang · 2020 · Cell Death and Disease
84. The disordered DNA-binding domain of p53 is indispensable for forming an encounter complex to and jumping along DNA
    Dwiky Rendra Graha Subekti, Kiyoto Kamagata · 2020 · Biochemical and Biophysical Research Communications
85. mTORC1 promotes mineralization via p53 pathway
    Xinghong Luo, Jingyao Yin, Shenghong Miao, Weiqing Feng, Tingting Ning, Shuaimei Xu, Shijiang Huang, Sheng Zhang, Yunjun Liao, Chunbo Hao et al. · 2021 · The FASEB Journal
86. In vivo evaluation of biodistribution and toxicity of pH-responsive strontium nanoparticles for gene delivery
    Athirah Bakhtiar, Aik Seng Neah, Khuen Yen Ng, Ezharul Hoque Chowdhury · 2021 · Journal of Pharmaceutical Investigation
87. Activation of the Akt– CREB signalling axis by a proline‐rich heptapeptide confers resistance to stress‐induced cell death and inflammation
    Johannes Herkel, Joerg Schrader, Neta Erez, Ansgar Wilhelm Lohse, Irun R. Cohen · 2017 · Immunology
88. SMAR1 and p53‐regulated lncRNA RP11 ‐ 431M3 .1 enhances HIF1A translation via miR ‐138 in colorectal cancer cells under oxidative stress
    Ganesh Suraj Bose, Shruti Jindal, Kiran B. Landage, Aarzoo Jindal, Monali Prakash Mahale, Abhijeet P. Kulkarni, Smriti P. K. Mittal · 2024 · FEBS Journal
89. Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia
    Emeline de Viron, Lucienne Michaux, Natalie Put, Françoise Bontemps, Eric Van Den Neste · 2012 · Leukemia & lymphoma/Leukemia and lymphoma
90. β-Actin facilitates etoposide-induced p53 nuclear import
    Wenjing Qi, Jinjiao Li, Xiaohua Pei, Yueshuang Ke, Qingpan Bu, Xiuzhen Ni · 2020 · Journal of Biosciences
91. p53 induction and cell viability modulation by genotoxic individual chemicals and mixtures
    Carolina Di Paolo, Yvonne M. F. Muller, Beat Thalmann, Henner Hollert, Thomas‐Benjamin Seiler · 2017 · Environmental Science and Pollution Research
92. Thiostrepton degrades mutant p53 by eliciting an autophagic response in SW480 cells
    Dhanya Kalathil, Manu Prasad, Maharrish Chelladurai, Samu John, S. Asha Nair · 2018 · Journal of Cellular Physiology
93. The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis
    Siddharth Singh, Manoj Kumar, Sanjeev Kumar, Shrinka Sen, Pawan Upadhyay, Sayan Bhattacharjee, M Naveen, Vivek Singh Tomar, Siddhartha Roy, Amit Dutt et al. · 2019 · Journal of Biological Chemistry
94. Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
    Michał Prendecki, Marta Kowalska, Ewa Totoń, Wojciech P. Kozubski · 2020 · Current Alzheimer Research
95. A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics
    Ruochong Wang, Guiquan Zhu · 2021 · Translational Cancer Research
96. P53 and taurine upregulated gene 1 promotes the repair of the DeoxyriboNucleic Acid damage induced by bupivacaine in murine primary sensory neurons
    Luying Lai, Yongwei Wang, Shenghui Peng, Wenjing Guo, Fengxian Li, Shiyuan Xu · 2022 · Bioengineered
97. P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway
    Zhijia Wang, Monika Mačáková, Andrii Bugai, Sergey G. Kuznetsov, Antti Hassinen, Tina Lenasi, Swapnil Potdar, Caroline C. Friedel, Matjaž Barborič · 2023 · Nucleic Acids Research
98. Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's ClubOplopanax horridusand Its Polyacetylene Bioactive Compound
    Susan S. C. Cheung, Joseph Tai, David Hasman, Dawei Ou, Garth L. Warnock · 2015 · Nutrition and Cancer
99. Exposure to Stress Alters Cardiac Gene Expression and Exacerbates Myocardial Ischemic Injury in the Female Murine Heart
    Hemangini A. Dhaibar, Lilly Kamberov, Natalie Carroll, Shripa Amatya, D. Djukic Cosic, Oscar Gómez, Shantel A. Vital, Farzane Sivandzade, Aditya Bhalerao, Salvatore Mancuso et al. · 2023 · International Journal of Molecular Sciences
100. Defining genome maintenance pathways using functional genomic approaches
     Carol E. Bansbach, David Cortez · 2011 · Critical Reviews in Biochemistry and Molecular Biology